medicines which might be substrates on the CYP3A enzyme as they may grow to be considerably less successful through cure with JOURNAVX. Your Health care provider might have to adjust the dose of your respective medicine when setting up or stopping JOURNAVXDue to the fact conolidine modulates ion channels and specific G protein-coupled receptors, ex